ICER Reveals Final Evidence Report on Three Multiple Myeloma Therapies
The Institute for Clinical and Economic Review (ICER) has announced a Final Evidence Report evaluating three therapies for use in [...]
Podcast on Succeeding as a Woman in Biotech and Business
Erin Jewell Consulting offers a podcast series highlighting the stories of women from different industries. A new podcast featuring Darla [...]
Upcoming Webinar on Managing Unconscious Bias
Unconscious bias and microaggressions can lead to poor workplace culture and unhappy employees. A webinar will cover how to recognize [...]
Aetion Announces $212 Million in Total Funding as RWE Momentum Builds
Aetion raised an additional $110 million in Series C funding, making its total funding $212 million. The real world evidence [...]
HealthEconomics.Com President Leads Discussion on New Scientist.com’s Value, Evidence and Access Marketplace, Notes Substantial Cost Benefits
HealthEconomics.Com President Dr. Patti Peeples spoke with Scientist.com Category Directory Maria Negron and Senior Director of Business Development David Brown. [...]
IQVIA Guide on RWD Applications in Drug Development Pipeline
IQVIA has released an eBook detailing when it’s appropriate to use real world evidence (RWE) and real world data (RWD). [...]
Upcoming Discussion on the Role of AI in Healthcare, COVID-19, and Equity
STAT recently published a report on artificial intelligence (AI), noting potential benefits such as lower healthcare costs and earlier disease [...]
Interactive Wednesday Webinar on Effective Medical Communication
Medical communication is becoming increasingly important for payers, pharma, and healthcare professionals. NetworkPharma will host a webinar this week on [...]
New Guide on Successfully Using RWE in Drug Development Pipeline
Using real world evidence (RWE) continues to be a valuable alternative to the traditional clinical trial. A new guide from [...]
Can Improved QALYs Effectively Reduce Drug Prices?
Dan Ollendorf of Tuft’s Center for the Evaluation of Value and Risk in Health (CEVR) shared his thoughts on how [...]
ISPOR’s Value in Health Discusses Economic Solutions to COVID-19 Pandemic
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)’s Value in Health journal published a themed collection of articles on COVID-19 [...]
New Article Discusses 35 Oncology Drugs Receiving Accelerated Approval
An article published in the New England Journal of Medicine (NEJM) discusses 35 oncology drugs that received accelerated approval from [...]
Amgen Leader Discusses Future Trends for Medical Affairs Professionals
Last year, the Medical Affairs Professional Society (MAPS) and Vice President of Amgen Europe Medical Affairs Dr. Isma Benattia announced [...]
MAPS Podcast on Virtual and Hybrid Events as COVID-19 Restrictions Ease
Medical Affairs Professional Society (MAPS) recently hosted a podcast with support from Impetus Digital. Impetus Digital CEO and Co-Founder Natalie [...]
Non-Legislative and Legislative Actions Could Reduce High Prescription Drug Prices
Reducing prescription drug prices in the United States continues to be a point of contention. Although legislative measures are expected [...]
Cytel Blog on Applying Bayesian Methods to COVID-19 Clinical Trials
A Cytel blog post discusses how Bayesian methods have impacted COVID-19 vaccine clinical trials. Using Bayesian statistics can improve study [...]
Lead Author of PRISMA 2020 Statement Discusses Research and Publication Trends
In a recent discussion with Matt Page, lead author of the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) [...]
ICER Publishes Draft Evidence Report on Alzheimer’s Disease Drug
The Institute for Clinical and Economic Review (ICER) published a Draft Evidence Report regarding Biogen’s aducanumab. The drug is designed to treat [...]
Model N and Global Pricing Innovations Partner to Improve Market Access
Model N and Global Pricing Innovations have announced a new partnership designed to improve market access. The companies are leaders [...]
PRMA Consulting Offers Concise Market Access Webinar
PRMA Consulting is offering a free 10-minute webinar on optimizing global and regional market access. The webinar will highlight common [...]
New Report Suggests Payer Profitability During COVID-19 Pandemic
A Kaiser Family Foundation brief points to increased profitability for payers during the COVID-19 pandemic. The research group noted that [...]
ISPOR Seeks Input Regarding Live Events
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is seeking your input regarding in-person events during its Europe 2021 [...]
JAMA Report on Reducing Prescription Drug Prices Using Legislation, Notes 159% List Price Increase in 11 Years
A new report discusses legislation that could reduce skyrocketing drug prices. Attempts at the state level have put forth unsupported [...]
BCG Report on Using RWE in Clinical Trials
A Boston Consulting Group (BCG) report discusses the benefits of real world evidence (RWE) in streamlining the clinical trial pipeline. [...]
Healthcare Communications Survey Seeks Your Input
The fourth yearly Healthcare Communications Workforce Insight Survey is taking responses. The survey was created by Paramount Recruitment along with [...]